Solutions & Services

LEUKOCARE’s SPS technologies to stabilize and protect proteins and biologics are covered by several patent families and the IP space is continuously updated along scientific progress.

LEUKOCARE offers technologies, know-how and experience for collaborative product development for formulation of vaccines and proteins, biologically functionalized medical devices and diagnostic applications.

LEUKOCARE’s business model is based on

• Out licensing the SPS technology for feasibility / research projects, product development or commercialization based on licenses and royalties
• Biological and chemical lab expertise
• Consulting services based on fee for service

LEUKOCARE’s in-house expertise covers physiology, biochemistry, biophysics, pharmaceutical technology, pharmacology, immunology, chemistry and medical engineering. LEUKOCARE has successfully in house designed, developed and clinically tested a biologic-combination device with therapeutic impact on the immune system (LIM). LEUKOCARE has also developed and patented a biochemical marker to monitor the activity of the immune system based on cell free DNA in blood plasma and a syringe-based filter disposable to derive hemolysis free blood plasma at point of care.

LEUKOCARE offers research and consulting services to integrate its SPS technology into new products including:

• Product planning and design by identifying suitable pathways and effector molecules
• Prototyping and product development work by exploring coupling technologies and formulation as well as stabilization aspects.
• Analytics by establishing and validating biological, biochemical or biophysical readouts
• Preclinical research by providing data concerning activity, stability, cytotoxicity and by establishing an animal model for delayed wound healing.
• Clinical research and registration by advising on regulatory aspects